반응식
[ClH:1].Cl.Cl.S1C(C2C=CN=C([NH:15][CH2:16][CH2:17][CH2:18][N:19]3[CH2:24][CH2:23][N:22]([CH3:25])[CH2:21][CH2:20]3)N=2)=CC2C=CC=CC1=2.[Br:30][C:31]1[CH:32]=[CH:33][C:34]2[CH:38]=[C:37]([C:39]3[C:44]([CH3:45])=[CH:43][N:42]=[C:41]([Cl:46])[N:40]=3)[S:36][C:35]=2[CH:47]=1.NCCCN1CCN(C)CC1>>[ClH:46].[ClH:1].[ClH:46].[Br:30][C:31]1[CH:32]=[CH:33][C:34]2[CH:38]=[C:37]([C:39]3[C:44]([CH3:45])=[CH:43][N:42]=[C:41]([NH:15][CH2:16][CH2:17][CH2:18][N:19]4[CH2:20][CH2:21][N:22]([CH3:25])[CH2:23][CH2:24]4)[N:40]=3)[S:36][C:35]=2[CH:47]=1참가 물질
4
실험 절차
Using the method of [4-(benzo[b]thiophen-2-yl)-pyrimidin-2-yl]-[3-(4-methylpiperazin-1-yl)-propyl]-amine tri-hydrochloride, the title compound is prepared from 4-(6-bromobenzo[b]thiophen-2-yl)-2-chloro-5-methylpyrimidine and 1-(3-aminopropyl)-4-methylpiperazine and isolated as a solid. ES+(m/z) 460 (79Br) and 462 (81Br) [M+H].
후처리
- customisolated as a solid
출처 및 근거
- ORD 기록
- ord-38ea2aa0a86446e19db7680f5c3a5637
- 출처 데이터셋
- uspto-grants-2009_06
- 특허 번호
- US07547691B2
연결된 노트
불러오는 중…